Corvus Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US2210151005

SecurityCRVS / Corvus Pharmaceuticals, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership123,896 shares
Latest Disclosed Value $ 1,812,598
Squarepoint Ops LLC reports 18.20% increase in ownership of CRVS / Corvus Pharmaceuticals, Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 123,896 shares of Corvus Pharmaceuticals, Inc. (US:CRVS) valued at $1,812,598 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 104,820 shares of Corvus Pharmaceuticals, Inc.. This represents a change in shares of 18.20% during the quarter. The current value of the position is $1,437,194 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 123,896 19,076 18.20 1,813 124.54 0.0021
2026-02-13 2025-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 104,820 104,820 807 0.0009
2025-11-14 2025-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 0 -138,462 -100.00 0 -100.00
2025-08-27 2025-06-30 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 138,462 37,430 37.05 554 72.27 0.0006
2025-08-14 2025-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 138,462 37,430 554 0.0006
2025-08-27 2025-03-31 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 101,032 2,888 2.94 321 -38.86 0.0004
2025-05-15 2025-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 101,032 2,888 321 0.0004
2025-02-14 2024-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 98,144 86,064 712.45 525 733.33 0.0005
2024-11-14 2024-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 12,080 12,080 64 0.0001
2023-11-14 2023-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 0 -17,082 -100.00 0 -100.00
2023-08-14 2023-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 17,082 17,082 39 0.0001
2022-05-16 2022-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 0 -13,118 -100.00 0 -100.00
2022-02-14 2021-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 13,118 -6,836 -34.26 32 -67.01 0.0001
2021-11-15 2021-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 19,954 19,954 97 0.0003
2020-11-16 2020-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 0 -26,418 -100.00 0 -100.00
2020-08-14 2020-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 26,418 1,982 8.11 72 38.46 0.0012
2020-05-15 2020-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 24,436 24,436 52 0.0013
2019-08-14 2019-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 0 -45,785 -100.00 0 -100.00
2019-05-15 2019-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 45,785 -27,669 -37.67 184 -31.85 0.0019
2019-02-14 2018-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 73,454 22,630 44.53 270 -38.07 0.0031
2018-11-14 2018-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 50,824 35,771 237.63 436 164.24 0.0052
2018-08-14 2018-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 15,053 1,675 12.52 165 7.14 0.0022
2018-05-15 2018-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 13,378 13,378 154 0.0024
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.